在人类心力衰竭中,心室激发 - 收缩合的跨体异质性和重塑
Qing Lou1, Vadim V Fedorov, Alexey V Glukhov
1Department of Biomedical Engineering, Washington University, St. Louis, MO, USA.
Circulation
|April 20, 2011
概括
心力衰竭改变了兴奋 - 收缩的合,导致人类心脏组织内处理的空间差异. 这项研究揭示了心脏衰竭的异质重塑,影响心脏功能.
科学领域:
- 心脏病学 心脏病学
- 生理学 生理学 生理学
- 生物化学 生物化学
背景情况:
- 兴奋 - 收缩 (EC) 合对心脏功能至关重要,已知在末期心力衰竭中会发生变化.
- 在衰竭的人类心脏的组织层面上EC合重塑的空间异质性仍然不太了解.
研究的目的:
- 研究EC合和处理在失败与非失败的人类心脏中的功能改造.
- 为了确定人类心脏组织中这些过程的空间异质性.
主要方法:
- 同时光学地图的动作潜力和的瞬态.
- 使用冠状动脉穿透的人类心脏的左心室准备.
- 在不同节奏率 (40和100 bpm) 下,心脏失败 (n=5) 和不失败 (n=6) 的比较.
主要成果:
- 失败的心脏显示较长的过时持续时间相对于动作潜力的时间在心期间下心脏.
- 在失败的心脏中,的过时持续时间的跨度梯度在失败的心脏中减少,速度更快.
- 在失败的心脏中观察到异常的过渡形状 (平坦的平原,2组件的上升).
- 慢慢的暂时放松和减少的质网膜Ca2+-ATPase 2a表达在心脏衰竭的心脏下内分泌体中被发现.
结论:
- 这项研究提供了第一个关于EC合和人类心脏中处理的跨肌肉异质性的实验证据.
- 末期心力衰竭的特点是EC合和处理过程的异质改造.
更多相关视频
09:37Permanent Ligation of the Left Anterior Descending Coronary Artery in Mice: A Model of Post-myocardial Infarction Remodelling and Heart Failure
Published on: December 2, 2014
27.4K
09:35Preclinical Cardiac Electrophysiology Assessment by Dual Voltage and Calcium Optical Mapping of Human Organotypic Cardiac Slices
Published on: June 16, 2020
9.6K
相关概念视频
Pathophysiology of Heart Failure
5.1K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
5.1K
Imbalances in Cardiac Output
3.3K
The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
3.3K
Mitral Regurgitation I: Introduction
1.3K
Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
1.3K
Heart Failure I: Introduction
2.0K
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
2.0K
Heart Failure II: Pathophysiology
2.1K
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
2.1K
Cardiomyopathy III: Hypertrophic Cardiomyopathy
810
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
810
